scispace - formally typeset
G

Gaochao Zhou

Researcher at Merck & Co.

Publications -  51
Citations -  10970

Gaochao Zhou is an academic researcher from Merck & Co.. The author has contributed to research in topics: Agonist & Peroxisome proliferator-activated receptor. The author has an hindex of 31, co-authored 51 publications receiving 10177 citations.

Papers
More filters
Journal ArticleDOI

Role of AMP-activated protein kinase in mechanism of metformin action

TL;DR: It is reported that metformin activates AMPK in hepatocytes; as a result, acetyl-CoA carboxylase (ACC) activity is reduced, fatty acid oxidation is induced, and expression of lipogenic enzymes is suppressed.
Journal ArticleDOI

AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome

TL;DR: Genetic and pharmacological studies demonstrate that AMPK is required for maintaining glucose homeostasis and holds a considerable potential to reverse the metabolic abnormalities associated with type 2 diabetes.
Journal ArticleDOI

Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes.

TL;DR: The findings suggest that the metabolic effects of metformin in subjects with type 2 diabetes may be mediated by the activation of AMPK alpha2, which is implicated in the stimulation of glucose uptake into skeletal muscle and the inhibition of liver gluconeogenesis.
Journal ArticleDOI

27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells.

TL;DR: 27-hydroxylation of cholesterol is an important pathway for LXR activation in response to cholesterol overload, and is concluded that 27-hydroxycholesterol functionally activated LXR.